Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucocorticoids and depression.

T Steckler1, F Holsboer, J M Reul

  • 1Max Planck Institute of Psychiatry, Munich, Germany.

Bailliere'S Best Practice & Research. Clinical Endocrinology & Metabolism
|July 25, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Non-Response to Antidepressants: Risk Factors and Therapeutic Possibilities.

Pharmacopsychiatry·2026
Same author

Antidepressant responsiveness in adulthood is permanently impaired after neonatal destruction of the neurogenic pool.

Translational psychiatry·2017
Same author

Proliferation rates and gene expression profiles in human lymphoblastoid cell lines from patients with depression characterized in response to antidepressant drug therapy.

Translational psychiatry·2016
Same author

The activity of the glucocorticoid receptor is regulated by SUMO conjugation to FKBP51.

Cell death and differentiation·2016
Same author

SLC6A15, a novel stress vulnerability candidate, modulates anxiety and depressive-like behavior: involvement of the glutamatergic system.

Stress (Amsterdam, Netherlands)·2015
Same author

Evidence for the role of corticotropin-releasing factor in major depressive disorder.

Neuroscience and biobehavioral reviews·2015
Same journal

Inhibin B in the assessment of seminiferous tubular function.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Post-Chernobyl thyroid carcinoma in children.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Surgical approach to thyroid nodules and cancer.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Diagnosis and treatment of medullary thyroid cancer.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Management of undifferentiated thyroid cancer.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
Same journal

Papillary and follicular thyroid carcinoma.

Bailliere's best practice & research. Clinical endocrinology & metabolism·2001
See all related articles

Depression is linked to abnormal stress hormone regulation via the hypothalamic-pituitary-adrenal (HPA) axis. Restoring HPA axis function through antidepressant treatment is crucial for alleviating depressive symptoms and achieving remission.

Area of Science:

  • Neuroendocrinology
  • Psychiatry
  • Molecular Biology

Background:

  • Depression is associated with dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis, including impaired mineralocorticoid receptor function and altered glucocorticoid receptor feedback.
  • Elevated cortisol levels and increased corticotropin-releasing factor activity are observed in depressed individuals, potentially contributing to the disorder's symptoms.
  • Both genetic predispositions and environmental factors, such as chronic stress, are implicated in the development of HPA axis abnormalities in depression.

Purpose of the Study:

  • To explore the relationship between HPA axis function and the pathophysiology of depression.
  • To investigate the role of neuroendocrine changes in depressive symptoms.
  • To determine if HPA axis normalization is essential for antidepressant treatment efficacy.

Related Experiment Videos

Main Methods:

  • Review of pre-clinical studies using genetically modified animals and chronic stress models.
  • Analysis of clinical evidence from human studies challenging the HPA system.
  • Examination of neuroendocrine and behavioral outcomes in response to HPA axis manipulation and antidepressant treatment.

Main Results:

  • Animal and human studies demonstrate neuroendocrine and behavioral changes comparable to depression when the HPA system is challenged.
  • Evidence suggests that HPA axis hyperactivity contributes to certain depressive symptoms.
  • Normalization of HPA axis function correlates with stable remission of depressive psychopathology following antidepressant treatment.

Conclusions:

  • HPA axis hyperactivity is a significant factor in the manifestation of depressive symptoms.
  • Antidepressant treatment's efficacy may depend on its ability to normalize HPA axis function.
  • Restoration of neuroendocrine balance is critical for the successful clinical management of depression.